Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells. | Front Immunol | 2023 | 37545491 | PubTator, text mining | PubMed |
| Identification and validation of a genetic risk signature associated with prognosis in clear-cell renal cell carcinoma patients. | Medicine (Baltimore) | 2023 | 37543772 | PubTator, text mining | PubMed |
| Medical Gas Plasma Technology Combines with Antimelanoma Therapies and Promotes Immune-Checkpoint Therapy Responses. | Adv Sci (Weinh) | 2023 | 37541287 | PubTator, text mining | PubMed |
| Cross-species single-cell transcriptomic analysis of animal gastric antrum reveals intense porcine mucosal immunity. | Cell Regen | 2023 | 37525021 | PubTator, text mining | PubMed |
| Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia. | iScience | 2023 | 37520727 | PubTator, text mining | PubMed |
| Smart Delivery Systems Responsive to Cathepsin B Activity for Cancer Treatment. | Pharmaceutics | 2023 | 37514035 | PubTator, text mining | PubMed |
| Bridging Pyroptosis and Immunity: A Comprehensive Study of the Pyroptosis-Related Long Non-Coding RNA Signature in Breast Cancer. | Life (Basel) | 2023 | 37511974 | PubTator, text mining | PubMed |
| Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression. | Int J Mol Sci | 2023 | 37511228 | PubTator, text mining | PubMed |
| Innate Immunity in Cancer Biology and Therapy. | Int J Mol Sci | 2023 | 37510993 | PubTator, text mining | PubMed |
| Insights into the New Molecular Updates in Acute Myeloid Leukemia Pathogenesis. | Genes (Basel) | 2023 | 37510328 | PubTator, text mining | PubMed |
| The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma. | Cancers (Basel) | 2023 | 37509400 | PubTator, text mining | PubMed |
| The Development and Role of Capmatinib in the Treatment of MET-Dysregulated Non-Small Cell Lung Cancer-A Narrative Review. | Cancers (Basel) | 2023 | 37509224 | PubTator, text mining | PubMed |
| Molecular Evolutionary Landscape of the Immune Microenvironment of Head and Neck Cancer. | Biomolecules | 2023 | 37509156 | PubTator, text mining | PubMed |
| Combination of Immunotherapy and Radiation Therapy in Gastrointestinal Cancers: An Appraisal of the Current Literature and Ongoing Research. | Curr Oncol | 2023 | 37504333 | PubTator, text mining | PubMed |
| Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension. | Pulm Circ | 2023 | 37502145 | PubTator, text mining | PubMed |
| Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies. | J Hematol Oncol | 2023 | 37501154 | PubTator, text mining | PubMed |
| Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models. | J Transl Med | 2023 | 37501121 | PubTator, text mining | PubMed |
| Proteomics Identifies Circulating TIMP-1 as a Prognostic Biomarker for Diffuse Large B-Cell Lymphoma. | Mol Cell Proteomics | 2023 | 37500057 | PubTator, text mining | PubMed |
| Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas. | Acta Neuropathol | 2023 | 37495858 | PubTator, text mining | PubMed |
| Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer. | Aging (Albany NY) | 2023 | 37494663 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=30